Koul S - Search Results

1

Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells.

Hisamori S, Mukohyama J, Koul S, Hayashi T, Rothenberg ME, Maeda M, Isobe T, Valencia Salazar LE, Qian X, Johnston DM, Qian D, Lao K, Asai N, Kakeji Y, Gennarino VA, Sahoo D, Dalerba P, Shimono Y. Hisamori S, et al. Among authors: koul s. J Gastroenterol. 2022 Jun;57(6):407-422. doi: 10.1007/s00535-022-01865-9. Epub 2022 Mar 4. J Gastroenterol. 2022. PMID: 35244768 Free PMC article.

2

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome.

Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M, Murty VV. Narayan G, et al. Among authors: koul s. Mol Cancer. 2003 May 13;2:24. doi: 10.1186/1476-4598-2-24. Mol Cancer. 2003. PMID: 12773202 Free PMC article.

3

Mouse Models of Germinal Center Derived B-Cell Lymphomas.

Meyer SN, Koul S, Pasqualucci L. Meyer SN, et al. Among authors: koul s. Front Immunol. 2021 Aug 12;12:710711. doi: 10.3389/fimmu.2021.710711. eCollection 2021. Front Immunol. 2021. PMID: 34456919 Free PMC article. Review.

4

Characteristic promoter hypermethylation signatures in male germ cell tumors.

Koul S, Houldsworth J, Mansukhani MM, Donadio A, McKiernan JM, Reuter VE, Bosl GJ, Chaganti RS, Murty VV. Koul S, et al. Mol Cancer. 2002 Nov 28;1:8. doi: 10.1186/1476-4598-1-8. Mol Cancer. 2002. PMID: 12495446 Free PMC article.

5

Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.

Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M, Reuter VE, Bosl GJ, Chaganti RS, Murty VV. Koul S, et al. Mol Cancer. 2004 May 18;3:16. doi: 10.1186/1476-4598-3-16. Mol Cancer. 2004. PMID: 15149548 Free PMC article.

6

Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression.

Narayan G, Pulido HA, Koul S, Lu XY, Harris CP, Yeh YA, Vargas H, Posso H, Terry MB, Gissmann L, Schneider A, Mansukhani M, Rao PH, Murty VV. Narayan G, et al. Among authors: koul s. Oncogene. 2003 May 29;22(22):3489-99. doi: 10.1038/sj.onc.1206432. Oncogene. 2003. PMID: 12776201

7

Mapping the sites of putative tumor suppressor genes at 6p25 and 6p21.3 in cervical carcinoma: occurrence of allelic deletions in precancerous lesions.

Chatterjee A, Pulido HA, Koul S, Beleño N, Perilla A, Posso H, Manusukhani M, Murty VV. Chatterjee A, et al. Among authors: koul s. Cancer Res. 2001 Mar 1;61(5):2119-23. Cancer Res. 2001. PMID: 11280775

8

Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations.

Liu X, Jia Y, Stoopler MB, Shen Y, Cheng H, Chen J, Mansukhani M, Koul S, Halmos B, Borczuk AC. Liu X, et al. Among authors: koul s. J Clin Oncol. 2016 Mar 10;34(8):794-802. doi: 10.1200/JCO.2015.62.0674. Epub 2015 Jul 27. J Clin Oncol. 2016. PMID: 26215952

9

Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer.

Stellas D, Szabolcs M, Koul S, Li Z, Polyzos A, Anagnostopoulos C, Cournia Z, Tamvakopoulos C, Klinakis A, Efstratiadis A. Stellas D, et al. Among authors: koul s. J Natl Cancer Inst. 2014 Oct 11;106(12):dju320. doi: 10.1093/jnci/dju320. Print 2014 Dec. J Natl Cancer Inst. 2014. PMID: 25306215

10

Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes.

Bourdon V, Naef F, Rao PH, Reuter V, Mok SC, Bosl GJ, Koul S, Murty VV, Kucherlapati RS, Chaganti RS. Bourdon V, et al. Among authors: koul s. Cancer Res. 2002 Nov 1;62(21):6218-23. Cancer Res. 2002. PMID: 12414650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

344 results

Search Page